FDA Approvals

Date Posted
Article Title
9/3/2009
Intuniv Approved for Pediatric ADHD

No known potential for abuse, maker says

8/31/2009
Valcyte Approved for Cytomegalovirus in Children

A leading cause of infection in transplant patients

8/28/2009
Zenpep Approved for Pancreatic Disorder

Makes up for lack of digestive enzymes

8/25/2009
Xyzal Approved for Younger Kids

Antihistamine sanctioned for children as young as 6 months

8/21/2009
Sabril Approved for Infantile Spasms

In children ages 1 month to 2 years

8/20/2009
New Hib Vaccine Granted Accelerated Approval

To help remedy vaccine shortage

8/18/2009
New Drug Approved for Gaucher Disease

An inherited metabolic disorder

8/17/2009
8/14/2009
8/4/2009
FDA Approves Avastin for Most Common Kidney Cancer

In combination with a second drug

8/4/2009
Livalo Approved for High Cholesterol

A risk factor for heart disease

8/3/2009
Sustained-Release Antipsychotic Approved for Schizophrenia

Invega Sustenna injected once monthly

7/31/2009
Onglyza Sanctioned for Type 2 Diabetes

A once-daily tablet to help control blood sugar

7/31/2009
Colcrys Approved for Acute Gout, Mediterranean Fever

Remedy long used to treat these two inflammatory conditions

7/24/2009
Forteo Approved for Drug-Related Osteoporosis

For people taking glucocorticoid medications

7/20/2009
Seasonal Flu Vaccine Approved

But it won't protect against swine flu

7/16/2009
Onsolis Approved for Severe Cancer Pain

Due to abuse risks, patch will be available under restricted distribution

7/10/2009
Effient Sanctioned for Angioplasty Patients

To reduce the risk of blood clots

7/6/2009
7/2/2009
Multaq Sanctioned for Heart Rhythm Disorders

Atrial fibrillation or atrial flutter